The pleural diseases market involves the treatment of various pleural disorders such as pleurisy, pneumothorax, pleural effusion and malignant mesothelioma. Pleural biopsy procedures play a vital role in the diagnosis and management of pleural diseases. Advancements in pleural biopsy devices such as sharp biopsy needles, biopsy forceps and biopsy catheters have enhanced the accuracy of pleural biopsy resulting in early diagnosis and effective treatment of pleural diseases. Pleural biopsy helps in identifying the underlying cause of pleural effusion including infections, malignancy or inflammation.

The Global pleural diseases market is estimated to be valued at US$ 5.76 Bn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Pleural Diseases Market Companies are Bristol Myers Squibb, Merck and Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.

The key opportunities in the pleural diseases market include rise in prevalence of malignant mesothelioma due to past asbestos exposure, increasing incidence of lung cancer and growing geriatric population.

Technological advancements in pleural biopsy devices such as digital imaging systems, automatic firing mechanisms and fine-caliber biopsy needles have improved the efficacy, safety and accessibility of pleural biopsy procedures.

Market drivers

The major Pleural Diseases Market Demand is rising prevalence of various pleural disorders globally. According to statistics, over 2 million people are estimated to develop pleural effusion annually worldwide. Increasing incidence of lung cancer, which commonly spreads to the pleural space, is another factor contributing to the growth of this market. Apart from this, product approvals and launches coupled with research and development activities undertaken by key players for developing advanced treatment options for pleural diseases will further propel the market growth during the forecast period.

Get more insights on Pleural Diseases Market

For More Insights Discover the Report In language that Resonates with you

French | German | Russian | Japanese | Chinese | Korean | Portuguese

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)